EUVIMEDEUVIMED entdecken
Fallbericht

Clinical and Molecular Evolution of an ALK -Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors

Nagore Gene-Olaciregui, Marta Perez-Somarriba iD, Vicente Santa-María iD, Ofelia Cruz, Soledad Gómez-González iD, Alicia Castañeda, Mariona Suñol, Carlota Rovira iD, Jordi Muchart iD, José Hinojosa iD, Andrés Morales La Madrid iD, Cinzia Lavarino iD

JCO Precision Oncology · 2023-03 · (7)

DOI: 10.1200/po.22.00547 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCO Precision Oncology, 2023-03. Verfasst von Nagore Gene-Olaciregui und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungGliomaLung NeoplasmsHumansInfantAnaplastic Lymphoma KinaseEvolution, MolecularProtein Kinase Inhibitors

Substanzen

Anaplastic Lymphoma KinaseProtein Kinase InhibitorsALK protein, human

Autor:innen und Institutionen

  • Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Neuro Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Laboratory of Developmental Tumor Biology, Institut de Recerca Sant Joan de Déu, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Pediatric Solid Tumor Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Department of Pathology, Hospital Sant Joan de Déu, Barcelona, Spain.

ORCID-Profile: Marta Perez-Somarriba, Vicente Santa-María, Soledad Gómez-González, Carlota Rovira, Jordi Muchart, José Hinojosa, Andrés Morales La Madrid, Cinzia Lavarino

Zitieren

APA

Gene-Olaciregui, N., Perez-Somarriba, M., Santa-María, V., Cruz, O., Gómez-González, S., Castañeda, A., Suñol, M., Rovira, C., Muchart, J., Hinojosa, J., La Madrid, A. M., & Lavarino, C. (2023). Clinical and Molecular Evolution of an ALK -Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors. JCO Precision Oncology. https://doi.org/10.1200/po.22.00547

Vancouver

Gene-Olaciregui N, Perez-Somarriba M, Santa-María V, Cruz O, Gómez-González S, Castañeda A, et al. Clinical and Molecular Evolution of an ALK -Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors. JCO Precision Oncology. 2023. doi:10.1200/po.22.00547

BibTeX
@article{GeneOlaciregui2023,
  author = {Gene-Olaciregui, Nagore and Perez-Somarriba, Marta and Santa-María, Vicente and Cruz, Ofelia and Gómez-González, Soledad and Castañeda, Alicia and Suñol, Mariona and Rovira, Carlota and Muchart, Jordi and Hinojosa, José and La Madrid, Andrés Morales and Lavarino, Cinzia},
  title = {Clinical and Molecular Evolution of an ALK -Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors},
  journal = {JCO Precision Oncology},
  year = {2023},
  number = {7},
  doi = {10.1200/po.22.00547}
}
Kostenlos starten →